Mednet
  • Contact
  • Service
  • Home
  • Mednet TV
    • Mednet TV live
    • Mednet TV on demand
    • Helpdesk
    • Accreditation
    • FAQ
  • Meetings
  • E-learning
  • News

To access all content on this website, please log in with your BSL Account.

Log in

Forgot your password?

No BSL Account yet? Please register.

Register

More information on BSL Accounts.

Category: Geen categorie

Post-hoc evidence presented in the second treatment session

SPR245 Banner 230x138 ERS int. Congress 2016During the second session about the treatment of patients with idiopathic pulmonary fibrosis (IPF), a lot of evidence from post-hoc, subgroup and/or pooled analyses were presented. However, the first lecture was about another topic: refractory chronic cough, which significantly improved with the use of inhaled PA101.

Read more »

Variation in clinical approaches in the picture

SPR245 Banner 230x138 ERS int. Congress 2016During the session ‘IPF clinical’, a wide range of topics about idiopathic pulmonary fibrosis (IPF) were presented, varying from cryobiopsies, comorbid emphysema, and the risks of prednisone use. For example, a French analysis showed that FVC may be unsuitable as a measure of disease progression in patients with a combination of IPF and ≥15% emphysema.

Read more »

Personalised medicine and patient-focused care in IPF

SPR245 Banner 230x138 ERS int. Congress 2016Personalised or patient-centered care is characterized by treating the individual and not the disease. During an evening symposium, organised by Boehringer Ingelheim, this concept was discussed by some key opinion leaders in the field of idiopathic pulmonary fibrosis (IPF).

Read more »

Registries offer new and useful insights

SPR245 Banner 230x138 ERS int. Congress 2016Registries are a useful way to learn about the clinical spectrum of interstitial lung diseases (ILDs) in different parts of the world. Furthermore, they offer data about the worldwide differences in diagnostic approaches and clinical management. Registries have become increasingly accepted as a valid source of data by the medical community.

Read more »

Negative and positive results in IPF treatment

SPR245 Banner 230x138 ERS int. Congress 2016There is an ongoing debate about whether anti-fibrotic agents should be started immediately after diagnosis of idiopathic pulmonary fibrosis (IPF) even in patients with relatively well-preserved lung function. A couple of presentations during the ERS Meeting shed some light on this debate.

Read more »

Early diagnosis of IPF: a patient journey

SPR245 Banner 230x138 ERS int. Congress 2016Owing to its complex and heterogeneous nature, and the need to differentiate it from other diseases with similar symptoms and radiological and histopathological features, idiopathic pulmonary fibrosis (IPF) is challenging to diagnose. During an evening symposium, organised by F. Hoffmann-La Roche and chaired by Athol Wells (London, United Kingdom), a group of experts discussed the early diagnosis and treatment of IPF.

Read more »

Complications and comorbidities in IPF are a major challenge

SPR245 Banner 230x138 ERS int. Congress 2016The two most common comorbidities that are associated with idiopathic pulmonary fibrosis (IPF) are emphysema and pulmonary hypertension (PH). Both worsen the prognosis of IPF. Furthermore, in one third of patients a combination of pulmonary fibrosis and emphysema (CPFE) exists. These comorbidities in IPF are a major challenge for physicians.

Read more »

New insights in IPF pathogenesis

SPR245 Banner 230x138 ERS int. Congress 2016In 2D versus 3D lung cultures, nintedanib and pirfenidone are found to decrease mesenchymal and epithelial fibrotic markers. A novel ex vivo method shows great potential to investigate important signaling pathways and mechanisms of early onset fibrosis for the identification of pro-fibrotic biomarkers.

Read more »

test Simone

Read more »

Springer Healthcare
Springer Healthcare

© 2023 Springer Healthcare, part of the Springer Nature group. All rights reserved.

  • Privacy
  • Disclaimer
  • Terms of service
  • Cookie settings